Bandar Al‐Judaibi
YOU?
Author Swipe
View article: The burden of metabolic dysfunction-associated steatotic liver disease and viral hepatitis in Saudi Arabia
The burden of metabolic dysfunction-associated steatotic liver disease and viral hepatitis in Saudi Arabia Open
Background: Globally, viral hepatitis is decreasing, but nonalcoholic fatty liver disease (NAFLD), now metabolic dysfunction-associated steatotic liver disease (MASLD), is increasing. We assessed the burden and trends of MASLD and viral he…
View article: The High Incidence of Occult Carcinoma in Total Hepatectomy Specimens of Patients Treated for Unresectable Colorectal Liver Metastases With Liver Transplant
The High Incidence of Occult Carcinoma in Total Hepatectomy Specimens of Patients Treated for Unresectable Colorectal Liver Metastases With Liver Transplant Open
Objective: To describe the rate of occult carcinoma deposits in total hepatectomy specimens from patients treated with liver transplant (LT) for colorectal liver metastases (CRLM). Background: Previous studies have shown that patients with…
View article: Saudi Association for the Study of Liver diseases and Transplantation position statement on the hepatology workforce in Saudi Arabia
Saudi Association for the Study of Liver diseases and Transplantation position statement on the hepatology workforce in Saudi Arabia Open
The field of hepatology has evolved significantly over the last two decades. Hepatology practice in Saudi Arabia (SA) was dominated by hepatitis B and C viruses but is now being overtaken by patients with non-alcoholic fatty liver disease.…
View article: The Saudi Critical Care Society Practice Guidelines on the Management of COVID-19 in the ICU: Therapy Section
The Saudi Critical Care Society Practice Guidelines on the Management of COVID-19 in the ICU: Therapy Section Open
BackgroundThe rapid increase in coronavirus disease 2019 (COVID-19) cases during the subsequent waves in Saudi Arabia and other countries prompted the Saudi Critical Care Society (SCCS) to put together a panel of experts to issue evidence-…
View article: Use of COVID-19 vaccines in patients with liver disease and post-liver transplantation
Use of COVID-19 vaccines in patients with liver disease and post-liver transplantation Open
Patients with chronic liver disease (CLD) and liver transplant recipients are at increased risk of morbidity and mortality from coronavirus disease 2019 (COVID-19). Although several studies demonstrated the safety and efficacy of COVID-19 …
View article: Saudi association for the study of liver diseases and transplantation position statement on liver transplantation during the COVID-19 pandemic
Saudi association for the study of liver diseases and transplantation position statement on liver transplantation during the COVID-19 pandemic Open
The World Health Organization (WHO), on March 11th 2020, upgraded the status of the novel coronavirus disease (COVID-19) from epidemic to pandemic. Over two million individuals have been infected with SARS-CoV-2, the virus causing COVID-19…
View article: Gastrointestinal and liver manifestations of COVID-19
Gastrointestinal and liver manifestations of COVID-19 Open
The novel coronavirus 2 (SARS-CoV-2) has spread worldwide. While patients typically present with fever and symptoms of a respiratory illness, patients have also presented with gastrointestinal symptoms such as diarrhea, vomiting and abdomi…
View article: Position statement on the diagnosis and management of non-alcoholic fatty liver disease
Position statement on the diagnosis and management of non-alcoholic fatty liver disease Open
Non-alcoholic fatty liver disease (NAFLD) is a major national and international health burden. It is one of the most common liver diseases worldwide and the most common cause of abnormal liver enzymes in many developed countries. Non-alcoh…
View article: Can we reduce ischemic cholangiopathy rates in donation after cardiac death liver transplantation after 10 years of practice? Canadian single-centre experience
Can we reduce ischemic cholangiopathy rates in donation after cardiac death liver transplantation after 10 years of practice? Canadian single-centre experience Open
Background: Outcomes in liver transplantation with organs obtained via donation after cardiocirculatory death (DCD) have been suboptimal compared to donation after brain death, attributed mainly to the high incidence of ischemic cholangiop…
View article: The role of imaging in determining prognosis for primary sclerosing cholangitis: A systematic review
The role of imaging in determining prognosis for primary sclerosing cholangitis: A systematic review Open
In conclusion, ERCP and MRCP-based indices have short-term prognostic value in PSC. However, more studies are required to validate their predictability of disease-related progression, such as liver decompensation, ascending cholangitis, ch…
View article: A166 SOFOSBUVIR-BASED THERAPY IN THE PRE-LIVER TRANSPLANT SETTING: THE CANADIAN NATIONAL EXPERIENCE
A166 SOFOSBUVIR-BASED THERAPY IN THE PRE-LIVER TRANSPLANT SETTING: THE CANADIAN NATIONAL EXPERIENCE Open
AIMS: To assess the efficacy of SOF-based therapy in HCV infected transplant eligible patients and to evaluate decompensated liver disease patients with respect to changes that occur in liver function in the short term and the resultant ef…
View article: A74 THE IMPACT OF SOFOSBUVIR-BASED THERAPY ON RENAL FUNCTION IN HEPATITIS C VIRUS PATIENTS WITH ADVANCED LIVER DISEASE
A74 THE IMPACT OF SOFOSBUVIR-BASED THERAPY ON RENAL FUNCTION IN HEPATITIS C VIRUS PATIENTS WITH ADVANCED LIVER DISEASE Open
BACKGROUND: Management of Hepatitis C virus (HCV) in chronic liver disease patients has been evolving over the past decade with the adoption of newer treatment strategies given the tolerability of these agents. HCV patients treated with So…